Skip to main content
OpenTrials
Completed

NCT Number: NCT03148080

Work Ability in Young Adult Cancer Survivors

To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Survivor

Age range

25 year–34 year

Sex eligibility

All sexes

Study type

Observational

Primary location

FHP Health Center-Guam, Tamuning, Guam

Loading trial locations.

About this study

This observational, cross-sectional study will recruit 220 analyzable YA survivors through the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base (WF NCORP RB). Data will be collected using a web-based interface and will capture physical, psychosocial and cognitive late effects; work ability; work-related outcomes, including labor force participation, occupation, work place characteristics, and educational attainment; survivor characteristics; and cancer diagnosis/treatment information (from clinical records). We will evaluate the relationships among these measures using the theoretical framework to guide statistical analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >= 2 to < 10 years post-cancer diagnosis (per diagnostic pathology report)
  • Diagnosed with first cancer (any type except types listed in exclusion criteria below) at age >= 15 years
  • Ability to understand and willingness to sign a written informed consent document
  • Must be able to read and understand English

Exclusion criteria

  • Currently receiving active cancer treatment (acceptable to be on maintenance or hormonal therapies)
  • Life expectancy less than 6 months
  • Precancerous or pre invasive conditions (myelodysplastic syndrome; carcinoma in situ; non-melanoma skin cancer) without progression to malignancy without another prior primary cancer diagnosis; (those who have had these conditions may participate IF they have a primary cancer diagnosis)
  • Non-Hispanic Whites (effective 11/01/2018)

Treatment and study plan

cognitive assessment

Procedure

Complete CogState

Questionnaire Administration

Other

Complete Self-Report Questionnaire

Primary outcomes

  1. Percentage of Participants Currently Employed

    Time frame: Baseline

    Labor force participation will be summarized as employed, unemployed (not working, but looking for work), and not in labor force (not employed and not looking for work or active duty military).

  2. Occupation Status

    Time frame: Baseline

    This categorical work-related outcomes will be described using frequencies. Occupational status will be summarized using the 2010 Standard Occupational Classification (SOC) system: managerial and professional) (SOC major groups 11-29), (support, retail, and service (SOC major groups 31-43), and construction, production and transportation (SOC major groups 45-53).

  3. Educational Attainment

    Time frame: Baseline

    This categorical work-related outcomes will be described using frequencies. Educational attainment will be classified as using the Current Population Survey classifications so that we can compare rates to US Benchmarks. The classifications are the following: Less than 1st grade, 1-4th grade, 5th-6th grade, 7-8th grade, 9th grade, 10th grade, 11th grade, 12 grade (no diploma), high school diploma or equivalent, some college (no degree), associate degree in college - occupational/vocational program, associate degree in college - academic program, Bachelor's degree, Master's degree, Professional School Degree (MD, DDS, DVM, JD etc.), Doctorate Degree.

  4. Financial Toxicity

    Time frame: Baseline

    The Comprehensive Score for Financial Toxicity (COST) is a self-report measure of financial distress experienced in response to cancer and its treatment. It ranges from 0-44, with higher scores associated with greater financial toxicity.

Secondary outcomes

  1. Work ability (measured by Work Ability Index global score)

    Time frame: Baseline

    The Work Ability Index score ranges from 7 to 49, with higher scores indicating better workability; the Work Ability Index (WAI) global score is an item within the Work Ability Index which measures work ability from 0 to 10, with 10 representing the best work ability.

  2. Work ability (measured by Work Ability Index)

    Time frame: Baseline

    The Work Ability Index (WAI) score ranges from 7 to 49, with higher scores indicating better workability; the Work Ability Index (WAI) global score is an item within the Work Ability Index which measures work ability from 0 to 10, with 10 representing the best work ability.

  3. Work ability measured by Work Limitations Questionnaire score

    Time frame: Baseline

    The Work Limitations Questionnaire (WLQ) is a self-report measure of impact of chronic health conditions/treatment on job performance. Subscales: (1) time demands; (2) physical demands; (3) mental-interpersonal demands; and (4) output demands. Scale scores range from 0 (limited none of the time) to 100 (limited all of the time) with 0 being better.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Work Ability in Young Adult Survivors (WAYS)

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
May 10, 2017
Registry last updated
Aug 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.